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Abstract: We formally evaluated waist circumference (WC) percentile
cutoffs for predicting insulin resistance (IR) and whether different cutoffs
should be used for adolescents of different race/ethnicities. Analysis was
performed for 1575 adolescents aged 12–18 yr from the National Health
and Nutrition Examination Survey 1999–2002. Adolescents were classi-
fied as having IR if they had a homeostasis model assessment-insulin
resistance level, a validated measure of IR, of .4.39, and WC percentile
was classified according to previously published universal (all races
combined) and race/ethnicity-specific WC percentile cutoffs. Receiver
operating characteristic curves for predicting IR were constructed
comparing the race/ethnicity-specific vs. universal WC percentile cutoffs,
and area under the curve (AUC) was calculated. Comparing universal
with race/ethnicity-specific WC percentiles, there were no significant
differences in AUC for Black, Mexican-American, or White adolescents.
Because race/ethnicity-specific thresholds did not discriminate better than
universal WC thresholds, universal WC thresholds may be used
effectively to identify adolescents with IR in primary care practices. A
WC 75th or 90th percentile for all race/ethnicities combined would be
appropriate to apply in clinical practice for identification of adolescents
with IR, a risk factor for development of type 2 diabetes.
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Visceral adiposity is associated with increased risk for
a variety of chronic diseases, including hypertension,
dyslipidemia, metabolic syndrome, and type 2 diabetes
(1).Waist circumference (WC) has been shown to be the
best anthropometric indicator of visceral obesity for
both adults (2) and children (3) and in adults predicts
risk for development of type 2 diabetes beyond
traditional cardiometabolic risk factors such as body
mass index (BMI), blood pressure, and lipid levels (4).
Based on recommendations from the National Heart
Lung and Blood Institute and the American Heart
Association, excess WC is defined by a WC .102 cm
for adult men and .88 cm for adult women (5).
Because WC normally increases from early childhood
through adolescence related to the dynamics of child-
hood growth and development, absolute WC thresh-
olds are not applicable to a pediatric population. One
recent consensus panel recommended that a WC
percentile cutoff of 90th percentile adjusted for age
and sex be used in children (6), but we are unaware of
any studies that have validated this WC cutoff using
physiologic outcome measures among children.
Insulin resistance (IR) is thought to play a critical role
in the pathogenesis of type 2 diabetes among children
(7). Recent studies have suggested that WC is an
independent predictor of IR, as measured by the
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homeostasis model assessment-insulin resistance
(HOMA-IR) and gold standard insulin clamp studies
(8, 9). Measurement of WC has therefore been advo-
cated for targeting high-risk individuals with IR for
diabetes screening and diabetes prevention interven-
tions in both the clinical and the research settings (10).
Although one adult study has validatedWC cutoffs for
predicting IR among adults (11), no such study exists
in children.
Because WC may serve as a simple, inexpensive, and
convenient tool for identifying children with IR in
pediatric clinical practice, we wished to formally
evaluate various WC percentile cutoffs for predicting
IR in a nationally representative, race/ethnically
diverse, population-based sample of adolescents. We
also sought to determine whetherWCpercentile cutoffs
should be different for adolescents of different race/
ethnicities as some studies have suggested that the
relation between visceral fat and IR may be differen-
tially modulated by race/ethnicity (12).
Methods and procedures
Study design
The National Health and Nutrition Examination
Survey (NHANES) is a cross-sectional, nationally
representative examination study of the US civilian
non-institutionalized population that uses a stratified
multistage probability sampling design (13) and over-
samples non-Hispanic Black and Mexican-American
individuals to provide reliable statistical estimates for
these subpopulations. Of the 4339 adolescents aged 12–
18 yr from NHANES 1999–2002, we analyzed data
from the subsample of 1647 adolescents who had
insulin and glucose measures after fasting for a mini-
mum of 8 h. We excluded participants who had self-
reported diabetes (n ¼ 4), were pregnant (n ¼ 26),
used medications that interfered with glucose metabo-
lism (corticosteroids, androgens, and antihypoglycemic
medications; n ¼ 25), or had missing WC measure-
ments (n ¼ 15). In this sample, unweighted estimates of
glucose tolerance status were classified as normal
glucose tolerance (glucose , 100; n ¼ 1389), impaired
fasting glucose (IFG) (100  glucose , 126; n ¼ 186),
and diabetes (glucose  126; n ¼ 2). We chose to
include adolescents with either normal fasting glucose
or IFG for this analysis (n ¼ 1575) because studies
have shown that the HOMA-IR is a valid surrogate
measure of IR for non-diabetic children (14).
When the 1575 adolescents included in the sample
were compared with those not included from the entire
sample of adolescents, there were no significant statis-
tical differences in gender (52.9 vs. 50.0%, p ¼ 0.20) or
mean age (14.99 vs. 14.97, p ¼ 0.80), although they did
have a slightly higher mean BMI z-score (0.49 vs. 0.38,
p ¼ 0.03).
Anthropometric measures and laboratory
procedures
A detailed description of the procedures for measur-
ing WC in subjects in NHANES by trained examiners
has been previously published (15). Procedures re-
garding assessment of fasting status, blood collection,
sample processing, and analysis of insulin and glucose
have also been described in detail in a previous
publication (16).
Data analysis
As is standard, HOMA-IR was calculated by dividing
the product of insulin (mU/mL) and glucose (mmol/L)
by 22.5. In our previous work using the same insulin
and glucose assays, we defined adolescents with
a HOMA-IR .4.39 as having IR, which was defined
by the upper 2.5 percentile HOMA-IR for normal-
weight adolescents with normal fasting glucose (rep-
resenting 2 SD from the mean) (16). Our selected
threshold was felt to be reasonable because it was
derived from a standard method for determining
abnormal values within a population (16). Although
we had evaluated other definitions of IR, we did not
select them as they were based on adult studies (11),
non-validatedmeasures of IR (17), or a definition of IR
based on distribution of HOMA-IR values for the
entire adolescent population, which included large
numbers of obese children (16).
Age-, sex-, and race/ethnicity-specific WC percentiles
(10th, 25th, 50th, 75th, and 90th) were used in this study
to be consistent with those generated from a nationally
representative sample previously publishedbyFernandez
et al. (18).
For the description of the overall sample, compar-
isons were made using t-tests and chi-squared analysis.
Receiver operator characteristic (ROC) curves were
constructed using these previously published universal
vs. race/ethnicity-specific WC percentile cutoffs to
predict IR for each of the three race/ethnicity groups.
ROC analysis is a formal method of assessment for
considering trade-offs between sensitivity and specifi-
city at various test cutoffs or thresholds. Area under the
curve (AUC) can be calculated from an ROC curve,
which is a measure of diagnostic accuracy, with 0.5
indicating a test with no test discrimination value and
1.0 indicating a test with perfect discrimination (19).
We performed statistical comparisons of AUC using
universal (all races combined) vs. race-specific WC
percentiles for each race/ethnicity group (White, Black,
and Mexican-American) using the roccomp function,
which tests the equality of two or more ROC areas. Of
the 1575 adolescents in the sample, 114 were classified
as ‘other’ race or ‘other Hispanic’ (not Mexican-
American). One final ROC curve was constructed
using universal WC percentiles for predicting IR for
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adolescents or all races, including adolescents from the
three racial/ethnic groups and adolescents of ‘other’
race/ethnicity.
Using similar methods as our previous study (16), we
also calculated HOMA-IR cutoffs for each race/
ethnicity group [.2 SD above the mean for Whites
(4.39), Blacks (5.71), and Mexican-Americans (4.69)].
In separate analyses, we constructed ROC curves
comparing universal vs. race/ethnicity-specific WC
percentiles for predicting IR using the race/ethnicity-
specific HOMA-IR cutoffs.
All statistical analyses were performed using STATA
9.0 (Stata Corporation, College Station, TX, USA),
which allows application of appropriate sampling
weights to adjust for the complex multicluster sample
design, including oversampling, subsampling of ado-
lescents with fasting glucose and insulin, and for
non-response. Therefore, the fasting subsample is
a nationally representative sample. Taylor series
linearization was used for variance estimation.
Results
Table 1 presents the demographic characteristics of the
study population, revealing no significant differences in
gender or age across the race/ethnicity groups. A higher
percentage of Black and Mexican-American adoles-
cents were overweight or obese and had IR compared
with White or adolescents of other race.
Figures 1–3 provide a comparison ofROC curves for
predicting IR using universal vs. age- and sex-adjusted
WC percentiles for each of the racial/ethnic groups.
There were no significant differences in AUC for Black
adolescents (0.83 for universal vs. 0.82 for race specific,
p ¼ 0.21), Mexican-American adolescents (0.84 for
universal vs. 0.85 for race specific, p ¼ 0.26), or White
adolescents (0.90 for universal vs. 0.90 for race specific,
p ¼ 0.64).
Separate analyses comparingROC curves using race-
specific HOMA-IR cutoffs resulted in essentially the
same results as that of the single cutoff of 4.39, showing
no significant differences in AUC for Black (0.82 for
universal vs. 0.80 for race specific, p ¼ 0.09), Mexican-
American (0.84 for universal vs. 0.85 for race specific,
p ¼ 0.26), or White adolescents (0.88 for universal vs.
0.89 for race specific, p ¼ 0.63) (data not shown).
Figure 4 provides the ROC curve for predicting IR
using age- and sex-adjusted universal WC thresholds
among adolescents of all races. Sensitivity was maxi-
mized at the lowest WC thresholds, and specificity was
maximized at the highest WC thresholds. So that the
thresholds may be easily referenced, table 2 presents
the age- and sex-specific universal WC thresholds for
the 75th and 90th percentiles, which were previously
published by Fernandez et al. (18).
Discussion
In our population-based, nationally representative
sample of US adolescents, we found that selected
race- and ethnicity-specific WC percentiles did not
discriminate better than universal WC percentiles for
identifying adolescents with IR. Therefore, we suggest
the use of universal WC percentiles rather than race-
and ethnicity-specific WC percentiles for evaluating
WC in adolescents. This practice would simplify the
use of IR screening in clinical settings vs. considering
separate cutoff points by race/ethnicity.
Table 1. Characteristics of the study population
Characteristics
Black
(n ¼ 440) (%)
Mexican-American
(n ¼ 592) (%)
White
(n ¼ 429) (%)
‘Other’ race
(n ¼ 114) (%) p-Value
Gender 0.58
Male 52.8 55.2 51.3 47.7
Female 47.2 44.8 48.7 52.3
Age (yr) 0.34
12 17.0 15.6 13.8 16.9
13 18.0 16.7 13.5 18.7
14 13.4 13.8 14.1 8.7
15 11.5 10.7 15.9 7.8
16 14.6 15.1 13.3 17.6
17 15.1 13.3 17.0 16.8
18 10.4 14.8 12.4 13.5
Weight status 0.01
Normal (BMI , 85th %) 59.0 62.6 75.0 72.7
Overweight (85th %  BMI , 95th %) 18.9 16.2 11.5 12.6
Obese (BMI  95th %) 22.1 21.2 13.5 14.7
% IRa 18.9 16.8 9.4 12.0 0.001
BMI, body mass index; HOMA-IR, homeostasis model assessment-insulin resistance; IR, insulin resistance.
n indicates the unweighted number of subjects. Percentages shown are weighted percentages.
aIR was defined by a HOMA-IR .4.39 (the upper 2.5 percentile HOMA-IR for normal-weight adolescents with normal
fasting glucose and representing 2 SD from the mean) (16).
Adolescent WC percentile cutoffs
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Fernandez et al. previously estimated age-, race-, and
sex-specific WC percentiles for adolescents and ado-
lescents aged 2 through 18 yr based on NHANES III
data (18). However, the various WC percentiles were
not related to any physiologic outcomes. Our study is
therefore unique in that we compared these WC
percentiles with a specific physiologic outcome – IR –
related to future risk of type 2 diabetes. Furthermore,
we performed formal comparison of universal vs.
race- and ethnicity-specific WC percentiles for each of
the sample subgroups by plotting ROC curves and
calculating AUC. We found no meaningful differences
in test performance, even after using race/ethnicity-
specific definitions of IR in separate analyses.
In another study, Katzmarzyk used data from the
Bogalusa Heart Study to evaluate the performance of
WC percentile thresholds for identifying individuals
with cardiovascular risk factor clustering (20). They
concluded that the optimal WC thresholds for identi-
fying individuals was at the 56th and 50th percentiles
for White and Black male subjects and at the 57th and
52nd percentiles for White and Black female subjects,
respectively. However, these race-specific WC percen-
tiles were not based on a nationally representative
sample, and they did not compare ROC curves for





























Fig. 1. Comparison of receiver operator characteristic curves for
predicting insulin resistance using universal vs. race-specific age-
and sex-adjusted waist circumference percentiles among Black
adolescents (p ¼ 0.21) (n ¼ 440).




























Fig. 2. Comparison of receiver operator characteristic curves for
predicting insulin resistance using universal vs. race-specific age-
and sex-adjusted waist circumference percentiles among Mexican-
American adolescents (p ¼ 0.26) (n ¼ 592).




























Fig. 3. Comparison of receiver operator characteristic curves for
predicting insulin resistance using universal vs. race-specific age-
and sex-adjusted waist circumference percentiles among White
adolescents (p ¼ 0.64) (n ¼ 429).


























Fig. 4. Receiver operator characteristic curve for predicting insulin
resistance using universal age- and sex-adjusted waist circumference
percentiles for all races combined, including White, Black, Mexican-
American, and adolescents of ‘other’ race/ethnicity (n ¼ 1575).
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Studies have shown that given the same degree of
adiposity, Black youths have higher levels of IR
compared with theirWhite counterparts (21, 22), which
may explain why Black adolescents are thought to be at
greater risk for development of type 2 diabetes. Given
these findings, one might postulate that there are race-
specific differences in the relationship between visceral
fat and IR, necessitating the use of race-specific WC
percentiles. However, studies have failed to demon-
strate that the relationship between visceral fat and IR
is differentially modulated by race. Bacha et al.
evaluated the association of high levels of visceral
adipose tissue asmeasured by abdominal computerized
tomography (CT) scan with insulin sensitivity, meas-
ured by hyperinsulinemic–euglycemic clamp, among 50
obese Black andWhite adolescents (12).When children
from both racial groups were divided into groups with
low and high visceral fat, Black andWhite childrenwith
high visceral fat demonstrated significant reductions in
peripheral insulin sensitivity to an equal degree (38%
decrease for both groups). Gower et al. also evaluated
for racial differences in the association between visceral
fat, measured by abdominal CT, and insulin sensitivity,
measured by the frequently sampled intravenous
glucose tolerance test, in a group of 61 Black and
White children. They found that there were no
significant differences in the association between
visceral fat and insulin sensitivity by race (23). The
findings from both of these studies using more
sophisticated measurement tools for visceral fat and
IR lend support to our finding that universal WC
percentiles may be applied to the entire population of
adolescents, although further validation of these WC
percentiles in other populations may be warranted
before their inclusion in routine clinical practice.
The International Diabetes Federation (IDF) desig-
nated a threshold of 90th% as one of the criteria for the
metabolic syndrome among children and adolescents
(6). However, when the IDF created a new definition of
the metabolic syndrome, they acknowledged that their
definition was created based on a number of studies
that empirically used the 90thWC percentile as a cutoff
and suggested that further studies could help clarify
whether this represents an appropriate threshold for
defining abnormality.
The selection of an optimal threshold value depends
on a number of factors, including the prevalence of IR,
the costs of various approaches to managing adoles-
cents with IR, and possible negative consequences of
falsely identifying adolescents with IR. Using the 90th
%WC threshold would ensure a high level of specificity
(91.4%) but at the expense of a lower sensitivity
(61.3%). As an example, WC could be utilized in the
primary care setting as a simple non-invasive screening
tool for determining which adolescents likely have IR
and should therefore undergo diagnostic testing for
carbohydrate abnormalities (prediabetes or type 2
diabetes). In this case, the 75th % WC threshold may
represent a more reasonable cutoff, as this would
improve sensitivity (86.1%), allowing detection of
a greater number of adolescents with carbohydrate
abnormalities. The higher number of false-positive
results (specificity 71.5%) associatedwith this threshold
may be acceptable, given that diagnostic testing for
prediabetes or type 2 diabetes is not extremely invasive
(requiring a simple venipuncture).
The American Diabetes Association (ADA) uses
BMI percentiles for designating which children should
be screened, recommending that children with a BMI
85th percentile for age and sex with any two
additional risk factors, including family history, race
or ethnicity, or signs of IR, should be screened for
diabetes (24). Because of the high burden of childhood
obesity, the Centers for Disease Control (CDC)
estimates that approximately 2.5 million children in
the USA potentially qualify for diabetes screening
based on the ADA screening guidelines (25), highlight-
ing the need for efficient and cost-effective strategies for
screening. Given that some studies in adults suggest
that WC is superior to BMI for explaining obesity-
related health risks (26), future studies are needed to
determine whether WC percentiles vs. BMI percentiles
are better and possibly more cost-effective for identi-
fying adolescents with IR. Furthermore, studies are
also needed to evaluate the validity of the proposedWC
cutoffs for identifying children with abnormal cardio-
vascular risk factors, such as systolic blood pressure,
triglycerides, and high-density lipoprotein cholesterol.
We used WC percentile cutoffs that were generated
based on a cohort of children from NHANES III
(1988–1994) (18) and applied them to the 1999–2002
NHANES sample. We feel that this was most
appropriate based on the fact that rates of obesity
and mean WC for children in the USA have increased
significantly between these two survey periods (15).
Creation of a new set of WC percentiles for the 1999–
2002 NHANES cohort that is heavier and of wider
girth would simply ‘normalize’ higher WC levels.
Furthermore, although fasting insulin levels may also
be used to screen for IR, that measure is not generally
Table 2. Age- and sex-specific waist circumference (cm)
thresholds designating the 75th and 90th percentiles for
adolescents of all races by Fernandez et al. (18)
Age (yr)
Boys Girls
75th % 90th % 75th % 90th %
12 74.3 84.8 73.5 82.7
13 76.8 88.2 75.9 85.8
14 79.4 91.6 78.3 88.8
15 81.9 95 80.7 91.9
16 84.5 98.4 83.1 94.9
17 87 101.8 85.5 98
18 89.6 105.2 87.9 101
Adolescent WC percentile cutoffs
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available in a routine primary care visit but rather would
require a return visit to a laboratory in a fasting state.
There are some limitations to our study. Because of
the lack of fasting glucose and insulin levels among
younger children, we were unable to evaluate WC
percentile thresholds for adolescents 11 yr and youn-
ger.We alsowere unable to assess the impact of puberty
onHOMA-IR levels because of lack of pubertal data in
NHANES. In addition, given that the data are cross-
sectional, we were unable to link childhood WC
thresholds to adult disease outcomes.
We recognize possible concerns regarding the defini-
tion of a HOMA-IR cutoff of.4.39 for defining IR, but
our sensitivity analyses using race-specific cutoffs for IR
yielded similar results. HOMA-IR is considered a vali-
dated measure of IR, with some studies showing
correlations of 0.7–0.9 (14, 27). However, other studies
have shown more modest correlations with clamp or
frequently sampled intravenous glucose tolerance test
(FSIVGTT) measures (28–30). Although HOMA-IR
may not be as sensitive a method for determining IR
compared with the gold standard methods of the
hyperinsulinemic–euglycemic clamp or the minimal
model frequently sampled intravenous glucose tolerance
test, it is unlikely thatmoredefinitivemeasurements using
these invasive and expensive gold standard methods will
be conducted in as large and diverse a population.
Studies have shown a high correlation between BMI
and WC, raising the question of whether WC offers
incremental utility above that of BMI. Although studies
are certainly needed to answer this question, the
establishment of abnormalWCpercentiles is first needed
so that comparison to standardized BMI percentiles can
be conducted. If future studies confirm the utility ofWC
in the clinical setting, further validation of this measure
in clinical practice may be warranted as WC measure-
ments may be subject to greater error compared with
BMI, particularly among young children.
Conclusions
In summary, race/ethnicity-specific WC percentile
thresholds did not discriminate better than universal
WC percentile thresholds, suggesting that universal
WC thresholds may be used effectively to identify
adolescents with IR in primary care practices. Appli-
cation of universal WC thresholds may simplify
implementation and adoption of WC as a screening
measure for diabetes risk among adolescents in primary
care and specialty care practices.
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